Cargando…
Methylation regulates HEY1 expression in glioblastoma
Glioblastoma (GBM) remains one of the most lethal and difficult-to-treat cancers of the central nervous system. The poor prognosis in GBM patients is due in part to its resistance to available treatments, which calls for identifying novel molecular therapeutic targets. In this study, we identified a...
Autores principales: | Tsung, Andrew J., Guda, Maheedhara R., Asuthkar, Swapna, Labak, Collin M., Purvis, Ian J., Lu, Yining, Jain, Neha, Bach, Sarah E., Prasad, Durbaka V.R., Velpula, Kiran K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546488/ https://www.ncbi.nlm.nih.gov/pubmed/28574840 http://dx.doi.org/10.18632/oncotarget.17897 |
Ejemplares similares
-
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
por: Guda, Maheedhara R., et al.
Publicado: (2019) -
Targeting RGS4 Ablates Glioblastoma Proliferation
por: Guda, Maheedhara R., et al.
Publicado: (2020) -
PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis
por: Elliott, Willie, et al.
Publicado: (2021) -
Galectin-1 activates carbonic anhydrase IX and modulates glioma metabolism
por: Guda, Maheedhara R., et al.
Publicado: (2022) -
B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role
por: Purvis, Ian J., et al.
Publicado: (2020)